Usha Menon

Q: What Schools Are Affiliated With Usha Menon

Usha Menon is affiliated with the following schools: University of Washington, University of Utah, University of Cambridge, University of Illinois Chicago, University of Calgary, University of Madras, Christian Medical College Vellore, University of Bristol, Drexel University, Amrita Vishwa Vidyapeetham, University of Copenhagen, Arizona State University, University of Bergen, Imperial College London, Ohio State University, University College London, University of Arizona, Vanderbilt University, University of South Florida

Usha Menon's AcademicInfluence.com Rankings

Usha Menon

Philosophy

#5907

World Rank

#8840

Historical Rank

Logic

#3118

World Rank

#4230

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Usha Menon Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Usha Menon is Professor of Gynaecological Cancer at University College London, described as "one of Britain’s foremost specialists in gynaecological cancer". She has been a lead investigator on UK ovarian cancer screening trials and on studies of ovarian cancer symptoms notably the UK Collaborative Trial of Ovarian Cancer Screening , which forms the evidence base for current ovarian cancer screening guidelines. UKCTOCS involved over 200,000 participants and 650,000 yearly screenings over a period of fourteen years with mortality as the endpoint.

(See a Problem?)

Usha Menon's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Rethinking ovarian cancer: recommendations for improving outcomes (2011) (1148)
Association analysis identifies 65 new breast cancer risk loci (2017) (922)
Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk (2015) (838)
Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). (2009) (790)
Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer. (2010) (788)
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer (2015) (778)
Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial (2016) (748)
Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies (2012) (745)
Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case–control studies (2012) (738)
Management of women who test positive for high-risk types of human papillomavirus: the HART study (2003) (600)
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes (2018) (559)
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer (2013) (534)
New tumor markers: CA125 and beyond (2005) (503)
Screening for ovarian cancer: a pilot randomised controlled trial (1999) (473)
Thyroid disorders in India: An epidemiological perspective (2011) (432)
Progress and Challenges in Screening for Early Detection of Ovarian Cancer* (2004) (426)
Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence (2019) (350)
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer (2013) (350)
A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24 (2010) (341)
Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study. (2013) (339)
Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer. (2015) (333)
An Epigenetic Signature in Peripheral Blood Predicts Active Ovarian Cancer (2009) (322)
A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2 (2009) (305)
Contribution of Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the Population. (2015) (262)
Development of a multimarker assay for early detection of ovarian cancer. (2010) (262)
Calculation of the risk of ovarian cancer from serial CA-125 values for preclinical detection in postmenopausal women. (2003) (262)
Prospective study using the risk of ovarian cancer algorithm to screen for ovarian cancer. (2005) (256)
Causal Associations of Adiposity and Body Fat Distribution With Coronary Heart Disease, Stroke Subtypes, and Type 2 Diabetes Mellitus: A Mendelian Randomization Analysis (2017) (239)
Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer (2017) (237)
Cancer survivors information seeking behaviors: a comparison of survivors who do and do not seek information about cancer. (2007) (235)
A Selective Allosteric Potentiator of the M1 Muscarinic Acetylcholine Receptor Increases Activity of Medial Prefrontal Cortical Neurons and Restores Impairments in Reversal Learning (2009) (221)
Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium. (2014) (187)
Ovarian cancer screening (2002) (183)
Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium. (2013) (180)
Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: a case-control study within the UKCTOCS cohort. (2011) (180)
Identification of six new susceptibility loci for invasive epithelial ovarian cancer (2014) (176)
PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS (2016) (174)
Discovery of Novel Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5 Reveals Chemical and Functional Diversity and In Vivo Activity in Rat Behavioral Models of Anxiolytic and Antipsychotic Activity (2010) (171)
A Breast Cancer Fear Scale: Psychometric Development (2004) (169)
Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer (2013) (167)
Predicting mammography and breast self-examination in African American women. (1997) (167)
Risk Algorithm Using Serial Biomarker Measurements Doubles the Number of Screen-Detected Cancers Compared With a Single-Threshold Rule in the United Kingdom Collaborative Trial of Ovarian Cancer Screening (2015) (164)
Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial (2021) (158)
Population Testing for Cancer Predisposing BRCA1/BRCA2 Mutations in the Ashkenazi-Jewish Community: A Randomized Controlled Trial (2014) (158)
Comparison of tailored interventions to increase mammography screening in nonadherent older women. (2003) (155)
Development of a self-efficacy scale for mammography. (2005) (150)
Epigenotyping in Peripheral Blood Cell DNA and Breast Cancer Risk: A Proof of Principle Study (2008) (150)
A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer (2018) (149)
Cost-effectiveness of Population Screening for BRCA Mutations in Ashkenazi Jewish Women Compared With Family History–Based Testing (2014) (148)
Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types. (2016) (146)
Preanalytic influence of sample handling on SELDI-TOF serum protein profiles. (2007) (146)
Ovarian cancer screening—Current status, future directions☆ (2014) (141)
Recruitment to multicentre trials—lessons from UKCTOCS: descriptive study (2008) (138)
Results of annual screening in phase I of the United Kingdom familial ovarian cancer screening study highlight the need for strict adherence to screening schedule. (2013) (135)
Views of BRCA gene mutation carriers on preimplantation genetic diagnosis as a reproductive option for hereditary breast and ovarian cancer. (2007) (130)
Cost-effectiveness of Population-Based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 Mutation Testing in Unselected General Population Women (2018) (128)
Why increasing availability of ART is not enough: a rapid, community-based study on how HIV-related stigma impacts engagement to care in rural South Africa (2015) (126)
Recent developments in ovarian cancer screening (2000) (125)
Factors influencing serum CA125II levels in healthy postmenopausal women. (2001) (124)
Associations between CYP2B6 polymorphisms and pharmacokinetics after a single dose of nevirapine or efavirenz in African americans. (2009) (123)
The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndrome (2019) (122)
Evidence of Stage Shift in Women Diagnosed With Ovarian Cancer During Phase II of the United Kingdom Familial Ovarian Cancer Screening Study (2017) (119)
Ovarian Cancer Prevention and Screening. (2018) (117)
Prevalence, frequency and problem rating of hot flushes persist in older postmenopausal women: impact of age, body mass index, hysterectomy, hormone therapy use, lifestyle and mood in a cross‐sectional cohort study of 10 418 British women aged 54–65 (2012) (114)
Validation of Scales to Measure Benefits of and Barriers to Colorectal Cancer Screening (2001) (112)
Outcome of risk‐reducing salpingo‐oophorectomy in BRCA carriers and women of unknown mutation status (2011) (112)
Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31 (2013) (110)
Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses (2019) (110)
Kali's tongue: Cultural psychology and the power of shame in Orissa, India. (1994) (107)
Breast cancer beliefs and mammography screening practices among Chinese American immigrants. (2007) (106)
Influences on multidisciplinary team decision-making (2007) (106)
The potential of circulating tumor DNA methylation analysis for the early detection and management of ovarian cancer (2017) (104)
Health behaviors in cancer survivors. (2007) (103)
Surgical morbidity associated with radical trachelectomy and radical hysterectomy. (2006) (101)
The sex hormone system in carriers of BRCA1/2 mutations: a case-control study. (2013) (99)
Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study. (2016) (96)
SCREENING FOR OVARIAN CANCER : A PILOT RANDOMISED CONTROLLED TRIAL (1999) (95)
Cigarette smoking and risk of ovarian cancer: a pooled analysis of 21 case–control studies (2013) (95)
Validity of self-reported mammography in low-income African-American women. (1998) (93)
Patient-centered care for Muslim women: provider and patient perspectives. (2011) (93)
Consortium analysis of 7 candidate SNPs for ovarian cancer (2008) (91)
Psychometric validation of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Endometrial Cancer Module (EORTC QLQ-EN24). (2011) (89)
ESR1/SYNE1 Polymorphism and Invasive Epithelial Ovarian Cancer Risk: An Ovarian Cancer Association Consortium Study (2010) (88)
Testing breast cancer serum biomarkers for early detection and prognosis in pre-diagnosis samples (2017) (87)
Colorectal cancer screening beliefs. Focus groups with first-degree relatives. (2000) (86)
Do benefits and barriers differ by stage of adoption for colorectal cancer screening? (2004) (86)
Microarray Glycoprofiling of CA125 improves differential diagnosis of ovarian cancer. (2013) (85)
Cervical cancer beliefs and pap test screening practices among Chinese American immigrants. (2007) (83)
LIN28B polymorphisms influence susceptibility to epithelial ovarian cancer. (2011) (82)
Genome-wide significant risk associations for mucinous ovarian carcinoma (2015) (81)
Beliefs Associated With Fecal Occult Blood Test and Colonoscopy Use at a Worksite Colon Cancer Screening Program (2003) (81)
Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51D (2020) (80)
Evaluation of serum CEA, CYFRA21-1 and CA125 for the early detection of colorectal cancer using longitudinal preclinical samples (2015) (80)
Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis. (2018) (80)
Population Distribution of Lifetime Risk of Ovarian Cancer in the United States (2015) (80)
Psychiatric Comorbidity and Functional Status in Adult Patients with Asthma (2001) (79)
BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers. (2016) (76)
Synthesis and evaluation of a series of heterobiarylamides that are centrally penetrant metabotropic glutamate receptor 4 (mGluR4) positive allosteric modulators (PAMs). (2009) (75)
The effect of telephone versus print tailoring for mammography adherence. (2007) (75)
Steroid hormone measurements from different types of assays in relation to body mass index and breast cancer risk in postmenopausal women: Reanalysis of eighteen prospective studies (2015) (74)
Comparisons of tailored mammography interventions at two months postintervention (2002) (72)
Risk of epithelial ovarian cancer in asymptomatic women with ultrasound‐detected ovarian masses: a prospective cohort study within the UK collaborative trial of ovarian cancer screening (UKCTOCS) (2012) (71)
Early detection of cancer in the general population: a blinded case–control study of p53 autoantibodies in colorectal cancer (2012) (70)
Prevalence and predictors of complementary and alternative medicine/non-pharmacological interventions use for menopausal symptoms within the UK Collaborative Trial of Ovarian Cancer Screening (2017) (70)
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer (2017) (70)
Health Belief Model Variables as Predictors of Progression in Stage of Mammography Adoption (2007) (70)
Biomarker-Based Ovarian Carcinoma Typing: A Histologic Investigation in the Ovarian Tumor Tissue Analysis Consortium (2013) (69)
Shared genetics underlying epidemiological association between endometriosis and ovarian cancer. (2015) (68)
A cost-effectiveness comparison of three tailored interventions to increase mammography screening. (2004) (68)
Decreased Serum Thrombospondin-1 Levels in Pancreatic Cancer Patients Up to 24 Months Prior to Clinical Diagnosis: Association with Diabetes Mellitus (2015) (66)
Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium study (2014) (65)
Evaluation of Candidate Stromal Epithelial Cross-Talk Genes Identifies Association between Risk of Serous Ovarian Cancer and TERT, a Cancer Susceptibility “Hot-Spot” (2010) (64)
Perceived Discrimination and Its Associations With Mental Health and Substance Use Among Asian American and Pacific Islander Undergraduate and Graduate Students (2014) (64)
A Randomized Trial Comparing the Effect of Two Phone-Based Interventions on Colorectal Cancer Screening Adherence (2011) (63)
Long-term follow-up of cervical disease in women screened by cytology and HPV testing: results from the HART study (2010) (63)
Knowledge and Beliefs Related to Cervical Cancer and Screening Among Korean American Women (2008) (63)
Common alleles in candidate susceptibility genes associated with risk and development of epithelial ovarian cancer (2011) (62)
HOXA methylation in normal endometrium from premenopausal women is associated with the presence of ovarian cancer: A proof of principle study (2009) (61)
Prognostic gene expression signature for high-grade serous ovarian cancer (2020) (61)
Autoantibodies to MUC1 glycopeptides cannot be used as a screening assay for early detection of breast, ovarian, lung or pancreatic cancer (2013) (61)
Ultrasound assessment of ovarian cancer risk in postmenopausal women with CA125 elevation (1999) (61)
Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study. (2016) (60)
Serum Peptide Profiling using MALDI Mass Spectrometry (2007) (60)
Vitamin D receptor rs2228570 polymorphism and invasive ovarian carcinoma risk: Pooled analysis in five studies within the Ovarian Cancer Association Consortium (2011) (59)
The impact of age and race on mammography practices. (2000) (59)
A BRCA1-mutation associated DNA methylation signature in blood cells predicts sporadic breast cancer incidence and survival (2014) (58)
Cost‐effectiveness of population based BRCA testing with varying Ashkenazi Jewish ancestry (2017) (58)
Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast–ovarian cancer susceptibility locus (2016) (58)
Screening for ovarian cancer in the general population. (2012) (57)
The Role of KRAS rs61764370 in Invasive Epithelial Ovarian Cancer: Implications for Clinical Testing (2011) (56)
Ovarian cancer screening in the general population: current status (2001) (56)
Breast cancer screening practices among first-generation immigrant muslim women. (2014) (56)
Performance of ultrasound as a second line test to serum CA125 in ovarian cancer screening (2000) (55)
Factors influencing uptake and timing of risk reducing salpingo‐oophorectomy in women at risk of familial ovarian cancer: a competing risk time to event analysis (2012) (55)
Improved early detection of ovarian cancer using longitudinal multimarker models (2020) (55)
Findings from focus groups indicating what Chinese American immigrant women think about breast cancer and breast cancer screening. (2012) (55)
Interventions to promote colorectal cancer screening: an integrative review. (2012) (55)
Functional Polymorphisms in the TERT Promoter Are Associated with Risk of Serous Epithelial Ovarian and Breast Cancers (2011) (53)
Appraising the role of previously reported risk factors in epithelial ovarian cancer risk: A Mendelian randomization analysis (2019) (53)
Association between invasive ovarian cancer susceptibility and 11 best candidate SNPs from breast cancer genome-wide association study. (2009) (53)
Osteoprotegerin (OPG), The Endogenous Inhibitor of Receptor Activator of NF-κB Ligand (RANKL), is Dysregulated in BRCA Mutation Carriers (2015) (53)
Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer (2019) (53)
A mindful eating intervention: A theory-guided randomized anti-obesity feasibility study with adolescent Latino females. (2016) (52)
Cancer-associated autoantibodies to MUC1 and MUC4—A blinded case–control study of colorectal cancer in UK collaborative trial of ovarian cancer screening (2013) (52)
Combined and Interactive Effects of Environmental and GWAS-Identified Risk Factors in Ovarian Cancer (2013) (52)
Ovarian and cervical cancer awareness: development of two validated measurement tools (2011) (51)
Laparoscopic extraperitoneal paraaortic lymphadenectomy: a study of its applications in gynecological malignancies. (2004) (51)
Predictive value of symptoms for ovarian cancer: comparison of symptoms reported by questionnaire, interview, and general practitioner notes. (2012) (51)
Perceptions of Colon Cancer Screening by Stage of Screening Test Adoption (2007) (51)
Screening practices in cancer survivors (2007) (51)
Decline in use of hormone therapy among postmenopausal women in the United Kingdom (2007) (50)
Epigenetic reprogramming of fallopian tube fimbriae in BRCA mutation carriers defines early ovarian cancer evolution (2016) (50)
A Genome-Wide Association Study Identifies A New Ovarian Cancer Susceptibility Locus On 9 p 22 . 2 (2010) (50)
Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer (2015) (50)
Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study (2018) (50)
Ovarian cancer symptom awareness and anticipated time to help-seeking for symptoms among UK women (2013) (49)
Specifying the ovarian cancer risk threshold of ‘premenopausal risk-reducing salpingo-oophorectomy’ for ovarian cancer prevention: a cost-effectiveness analysis (2016) (49)
Assess the Effects of Culturally Relevant Intervention on Breast Cancer Knowledge, Beliefs, and Mammography Use Among Korean American Women (2010) (48)
Feasibility of screening for ovarian cancer using symptoms as selection criteria * (2006) (48)
Ovarian cancer screening: Current status and future directions. (2020) (47)
An investigation of routes to cancer diagnosis in 10 international jurisdictions, as part of the International Cancer Benchmarking Partnership: survey development and implementation (2016) (46)
Heritage, health and well-being: assessing the impact of a heritage focused intervention on health and well-being (2013) (46)
Pre- and postintervention differences in acculturation, knowledge, beliefs, and stages of readiness for mammograms among Korean American women. (2009) (46)
Validating genetic risk associations for ovarian cancer through the International Ovarian Cancer Association Consortium (2009) (45)
Impact on mortality and cancer incidence rates of using random invitation from population registers for recruitment to trials (2011) (45)
Motivational interviewing and colorectal cancer screening: a peek from the inside out. (2008) (45)
Ovarian cancer screening (1998) (45)
Diagnostic routes and time intervals for patients with colorectal cancer in 10 international jurisdictions; findings from a cross-sectional study from the International Cancer Benchmarking Partnership (ICBP) (2018) (45)
Predictors of complications in gynaecological oncological surgery: a prospective multicentre study (UKGOSOC—UK gynaecological oncology surgical outcomes and complications) (2014) (44)
The 2014-2018 Oncology Nursing Society Research Agenda. (2015) (44)
A combined biomarker panel shows improved sensitivity for the early detection of ovarian cancer allowing the identification of the most aggressive type II tumours (2017) (43)
Rural–Urban Disparities in Time to Diagnosis and Treatment for Colorectal and Breast Cancer (2018) (43)
Methylation patterns in serum DNA for early identification of disseminated breast cancer (2017) (43)
Cell cycle genes and ovarian cancer susceptibility: a tagSNP analysis (2009) (42)
Breast and cervical cancer screening practices and inventions among Chinese, Japanese, and Vietnamese Americans. (2005) (42)
Use of surgical task shifting to scale up essential surgical services: a feasibility analysis at facility level in Uganda (2013) (42)
Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10. (2014) (42)
A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases (2019) (41)
Aberrant regulation of RANKL/OPG in women at high risk of developing breast cancer (2016) (41)
Elevation of TP53 Autoantibody Before CA125 in Preclinical Invasive Epithelial Ovarian Cancer (2017) (41)
Beyond Social Desirability Bias: Investigating Inconsistencies in Self-Reported HIV Testing and Treatment Behaviors Among HIV-Positive Adults in North West Province, South Africa (2018) (41)
A well‐characterised peak identification list of MALDI MS profile peaks for human blood serum (2010) (41)
The ConNECT Framework: a model for advancing behavioral medicine science and practice to foster health equity (2017) (40)
Assessing the malignant potential of ovarian inclusion cysts in postmenopausal women within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a prospective cohort study (2012) (40)
Protein Z: A putative novel biomarker for early detection of ovarian cancer (2016) (40)
Discovery of 2‐(2‐Benzoxazoyl amino)‐4‐Aryl‐5‐Cyanopyrimidine as Negative Allosteric Modulators (NAMs) of Metabotropic Glutamate Receptor 5 (mGlu5): From an Artificial Neural Network Virtual Screen to an In Vivo Tool Compound (2012) (40)
Psychological morbidity associated with ovarian cancer screening: results from more than 23 000 women in the randomised trial of ovarian cancer screening (UKCTOCS) (2014) (40)
The effect of a couples intervention to increase breast cancer screening among korean americans. (2014) (39)
Association of serum sex steroid receptor bioactivity and sex steroid hormones with breast cancer risk in postmenopausal women (2011) (39)
PPM1D Mosaic Truncating Variants in Ovarian Cancer Cases May Be Treatment-Related Somatic Mutations. (2016) (39)
Discovery of serum biomarkers of ovarian cancer using complementary proteomic profiling strategies (2014) (39)
Advanced-stage cancer and time to diagnosis: An International Cancer Benchmarking Partnership (ICBP) cross-sectional study. (2019) (39)
Annual outpatient hysteroscopy and endometrial sampling (OHES) in HNPCC/Lynch syndrome (LS) (2012) (38)
Circulating Methylated DNA: A New Generation of Tumor Markers (2006) (38)
Serum inhibin, activin and follistatin in postmenopausal women with epithelial ovarian carcinoma (2000) (38)
Recruitment of newly diagnosed ovarian cancer patients proved challenging in a multicentre biobanking study. (2011) (37)
Understanding traditional and modern eating: the TEP10 framework (2019) (37)
Current detection rates and time-to-detection of all identifiable BRCA carriers in the Greater London population (2018) (37)
Evaluation in pre-diagnosis samples discounts ICAM-1 and TIMP-1 as biomarkers for earlier diagnosis of pancreatic cancer. (2015) (37)
Delay in diagnostic testing after abnormal mammography in low-income women. (2009) (37)
Randomised trial of population‐based BRCA testing in Ashkenazi Jews: long‐term outcomes (2019) (37)
Hereditary non-polyposis colorectal cancer or Lynch syndrome: the gynaecological perspective (2009) (37)
Cluster-randomised non-inferiority trial comparing DVD-assisted and traditional genetic counselling in systematic population testing for BRCA1/2 mutations (2016) (37)
Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer Risk (2015) (36)
Tagging single-nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer (2009) (36)
Analyzing Emotions as Culturally Constructed Scripts (2000) (36)
Peptides generated ex vivo from serum proteins by tumor-specific exopeptidases are not useful biomarkers in ovarian cancer. (2010) (35)
Ovarian Cancer Screening in the General Population (2003) (35)
Breast and Cervical Cancer Screening Among South Asian Immigrants in the United States (2012) (35)
Anti-homosexual legislation and HIV-related stigma in African nations: what has been the role of PEPFAR? (2017) (35)
Awareness of ovarian cancer risk factors, beliefs and attitudes towards screening: baseline survey of 21 715 women participating in the UK Collaborative Trial of Ovarian Cancer Screening (2010) (33)
Evaluation of polygenic risk scores for ovarian cancer risk prediction in a prospective cohort study (2018) (33)
Interactive, Culturally Sensitive Education on Colorectal Cancer Screening (2008) (33)
Comparison of Longitudinal CA125 Algorithms as a First-Line Screen for Ovarian Cancer in the General Population (2018) (33)
Defining the risk threshold for risk reducing salpingo-oophorectomy for ovarian cancer prevention in low risk postmenopausal women. (2015) (32)
Tailoring interventions for health behavior change in breast cancer screening. (1997) (32)
Korean American Women and Mammogram Uptake (2016) (32)
An assessment of data quality in a multi-site electronic medical record system in Haiti (2016) (32)
Association Between Menopausal Estrogen-Only Therapy and Ovarian Carcinoma Risk (2016) (32)
Vascular endothelial growth factor gene polymorphisms and ovarian cancer survival. (2010) (32)
Attrition and Opportunities Along the HIV Care Continuum: Findings From a Population-Based Sample, North West Province, South Africa (2016) (31)
A Breast Health Educational Program for Chinese-American Women: 3- to 12-Month Postintervention Effect (2015) (31)
Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium (2015) (31)
Identifying hopelessness in population research: a validation study of two brief measures of hopelessness (2014) (31)
Ovarian cancer screening and mortality. (2011) (30)
Serum Proteomic Abnormality Predating Screen Detection of Ovarian Cancer (2009) (30)
Adverse event profile of a mature voluntary medical male circumcision programme performing PrePex and surgical procedures in Zimbabwe (2017) (29)
The role of peritoneal cytology at risk-reducing salpingo-oophorectomy (RRSO) in women at increased risk of familial ovarian/tubal cancer. (2012) (29)
Did PEPFAR investments result in health system strengthening? A retrospective longitudinal study measuring non-HIV health service utilization at the district level (2016) (29)
Genetic Data from Nearly 63,000 Women of European Descent Predicts DNA Methylation Biomarkers and Epithelial Ovarian Cancer Risk. (2018) (29)
Using Museum Objects to Improve Wellbeing in Mental Health Service Users and Neurological Rehabilitation Clients (2013) (28)
Utility of Gallium‐68 DOTANOC PET/CT in the localization of Tumour‐induced osteomalacia (2016) (28)
Quantitative evidence for wellbeing benefits from a heritage-in-health intervention with hospital patients (2012) (28)
Germline whole exome sequencing and large-scale replication identifies FANCM as a likely high grade serous ovarian cancer susceptibility gene. (2017) (28)
Early detection of ovarian cancer in samples pre-diagnosis using CA125 and MALDI-MS peaks. (2011) (28)
Racial and Educational Differences in Mammography-Related Perceptions Among 1,336 Nonadherent Women (2002) (27)
Measuring Breast Cancer and Mammography Screening Beliefs Among Chinese American Immigrants (2008) (27)
Genetic variation in insulin-like growth factor 2 may play a role in ovarian cancer risk. (2011) (27)
Cost effectiveness of population based BRCA1 founder mutation testing in Sephardi Jewish women (2017) (27)
Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE) (2020) (27)
Correlates of Colorectal Cancer Screening Among South Asian Immigrants in the United States (2014) (26)
Common Genetic Variation in Circadian Rhythm Genes and Risk of Epithelial Ovarian Cancer (EOC) (2015) (26)
Experience of symptoms indicative of gynaecological cancers in UK women (2013) (26)
Incentives and barriers to implementing national hospital standards in Uganda. (2009) (26)
Synthesis and SAR of novel, 4-(phenylsulfamoyl)phenylacetamide mGlu4 positive allosteric modulators (PAMs) identified by functional high-throughput screening (HTS). (2010) (26)
Classification and rates of adverse events in a Malawi male circumcision program: impact of quality improvement training (2016) (25)
Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium (2020) (25)
Mixed methods evaluation of well-being benefits derived from a heritage-in-health intervention with hospital patients (2013) (25)
Progesterone receptor gene polymorphisms and risk of endometriosis: results from an international collaborative effort. (2011) (25)
Enhancing cancer patient well-being with a nonpharmacological, heritage-focused intervention. (2012) (25)
Using the Health Belief Model to Examine Differences in Adherence to Mammography Among African-American and Caucasian Women (2003) (25)
Use and perceived efficacy of complementary and alternative medicines after discontinuation of hormone therapy: a nested United Kingdom Collaborative Trial of Ovarian Cancer Screening cohort study (2015) (25)
Estrogen Receptor Beta rs1271572 Polymorphism and Invasive Ovarian Carcinoma Risk: Pooled Analysis within the Ovarian Cancer Association Consortium (2011) (24)
Investigating the therapeutic potential of a heritage-object focused intervention: a qualitative study (2012) (24)
Improvements in the South African HIV care cascade: findings on 90‐90‐90 targets from successive population‐representative surveys in North West Province (2019) (24)
Diagnosis of epithelial ovarian cancer using a combined protein biomarker panel (2019) (24)
Cervical Cancer Screening Among Arab Women in the United States: An Integrative Review. (2017) (24)
Success factors for implementing and sustaining a mature electronic medical record in a low-resource setting: a case study of iSanté in Haiti (2018) (24)
Generic well-being outcomes: towards a conceptual framework for well-being outcomes in museums (2011) (24)
Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA (2013) (24)
Psychological outcomes of familial ovarian cancer screening: no evidence of long-term harm. (2012) (23)
Making Śakti: Controlling (Natural) Impurity for Female (Cultural) Power (2002) (23)
Cigarette smoking is associated with adverse survival among women with ovarian cancer: Results from a pooled analysis of 19 studies (2017) (23)
Universalism without Uniformity: Explorations in Mind and Culture (2017) (23)
Evaluation of short message service and peer navigation to improve engagement in HIV care in South Africa: study protocol for a three-arm cluster randomized controlled trial (2016) (23)
The UKCTOCS Experience—Reasons for Hope? (2012) (23)
The cost-effectiveness of screening for ovarian cancer: results from the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) (2017) (23)
Engaging HIV-positive clients in care: acceptability and mechanisms of action of a peer navigation program in South Africa (2018) (22)
Assessing the genetic architecture of epithelial ovarian cancer histological subtypes (2016) (22)
Acceptance of transvaginal sonography by postmenopausal women participating in the United Kingdom Collaborative Trial of Ovarian Cancer Screening (2013) (22)
Analysis of Over 10,000 Cases Finds No Association between Previously Reported Candidate Polymorphisms and Ovarian Cancer Outcome (2013) (22)
Cameroon mid-level providers offer a promising public health dentistry model (2012) (22)
3-Cyano-5-fluoro-N-arylbenzamides as negative allosteric modulators of mGlu(5): Identification of easily prepared tool compounds with CNS exposure in rats. (2010) (22)
Time to diagnosis of Type I or II invasive epithelial ovarian cancers: a multicentre observational study using patient questionnaire and primary care records (2015) (22)
Parenclitic networks for predicting ovarian cancer (2018) (22)
Population-based targeted sequencing of 54 candidate genes identifies PALB2 as a susceptibility gene for high-grade serous ovarian cancer (2019) (22)
Genetic Variation in TYMS in the One-Carbon Transfer Pathway Is Associated with Ovarian Carcinoma Types in the Ovarian Cancer Association Consortium (2010) (22)
Attitude towards and factors affecting uptake of population‐based BRCA testing in the Ashkenazi Jewish population: a cohort study (2019) (22)
The association between socioeconomic status and tumour stage at diagnosis of ovarian cancer: A pooled analysis of 18 case-control studies. (2016) (21)
MyD88 and TLR4 Expression in Epithelial Ovarian Cancer (2018) (21)
Serial Patterns of Ovarian Cancer Biomarkers in a Prediagnosis Longitudinal Dataset (2015) (21)
Epithelial‐Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk (2015) (21)
GRK5 Gln41Leu polymorphism is not associated with sensitivity to beta(1)-adrenergic blockade in humans. (2009) (21)
Polymorphism in the IL18 Gene and Epithelial Ovarian Cancer in Non-Hispanic White Women (2008) (21)
Serum HE4 and diagnosis of ovarian cancer in postmenopausal women with adnexal masses (2020) (21)
Large-Scale Evaluation of Common Variation in Regulatory T Cell–Related Genes and Ovarian Cancer Outcome (2014) (20)
Functional complementation studies identify candidate genes and common genetic variants associated with ovarian cancer survival. (2009) (20)
Development of an Electronic Medical Record Based Alert for Risk of HIV Treatment Failure in a Low-Resource Setting (2014) (20)
Tailored interventions for screening mammography among a sample of initially non-adherent women: when is a booster dose important? (2007) (20)
(3-Cyano-5-fluorophenyl)biaryl negative allosteric modulators of mGlu(5): Discovery of a new tool compound with activity in the OSS mouse model of addiction. (2011) (20)
Enhanced GAB2 Expression Is Associated with Improved Survival in High-Grade Serous Ovarian Cancer and Sensitivity to PI3K Inhibition (2015) (20)
Circulating Fatty Acids and Risk of Coronary Heart Disease and Stroke: Individual Participant Data Meta‐Analysis in Up to 16 126 Participants (2020) (20)
A comparison of national cancer registry and direct follow-up in the ascertainment of ovarian cancer (1999) (20)
The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer (2019) (20)
Ovarian cancer: challenges of early detection (2007) (19)
MicroRNA Processing and Binding Site Polymorphisms Are Not Replicated in the Ovarian Cancer Association Consortium (2011) (19)
Conformal predictors in early diagnostics of ovarian and breast cancers (2012) (19)
Evidence of Altered Glycosylation of Serum Proteins Prior to Pancreatic Cancer Diagnosis (2017) (19)
Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci (2017) (19)
Morality and Context: A Study of Hindu Understandings (2005) (19)
Evaluating the therapeutic effects of museum object handling with hospital patients: A review and initial trial of wellbeing measures (2011) (18)
Highly Accurate Detection of Ovarian Cancer Using CA125 but Limited Improvement With Serum Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry Profiling (2010) (18)
Pivotal role of families in doctor‐patient communication in oncology: a qualitative study of patients, their relatives and cancer clinicians (2017) (18)
Discourse of Anthropology and the Domestic Life of Hindu Women (2008) (18)
Identification of a serum biomarker panel for the differential diagnosis of cholangiocarcinoma and primary sclerosing cholangitis (2018) (18)
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. (2016) (18)
Screening for ovarian cancer (1999) (18)
Age- and Sex-Specific Cancer Prevention and Screening Practices Among Asian Indian Immigrants in the United States (2011) (17)
Human epididymis protein 4 antigen‐autoantibody complexes complement cancer antigen 125 for detecting early‐stage ovarian cancer (2019) (17)
Timing of adverse events among voluntary medical male circumcision clients: Implications from routine service delivery in Zimbabwe (2018) (17)
A qualitative assessment of challenges to tuberculosis management and prevention in Northern Ethiopia. (2013) (17)
Implementing voluntary medical male circumcision using an innovative, integrated, health systems approach: experiences from 21 districts in Zimbabwe (2018) (17)
Evaluating the ovarian cancer gonadotropin hypothesis: a candidate gene study. (2015) (17)
Factors Affecting Short-term Mortality in Women With Ovarian, Tubal, or Primary Peritoneal Cancer: Population-Based Cohort Analysis of English National Cancer Registration Data (2015) (17)
Feasibility of a targeted breast health education intervention for Chinese American immigrant women. (2013) (17)
Validity of self-reported hysterectomy: a prospective cohort study within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) (2014) (17)
Withdrawal from familial ovarian cancer screening for surgery: findings from a psychological evaluation study (PsyFOCS). (2012) (17)
Screening for Ovarian Cancer (2004) (17)
Use of common analgesic medications and ovarian cancer survival: results from a pooled analysis in the Ovarian Cancer Association Consortium (2017) (17)
Time intervals and routes to diagnosis for lung cancer in 10 jurisdictions: cross-sectional study findings from the International Cancer Benchmarking Partnership (ICBP) (2019) (17)
The Sine Qua Non of Discovering Novel Biomarkers for Early Detection of Ovarian Cancer: Carefully Selected Preclinical Samples (2011) (16)
Sexual functioning in 4,418 postmenopausal women participating in UKCTOCS: a qualitative free-text analysis (2019) (16)
Measuring quality and outcomes of research collaborations: An integrative review (2019) (16)
Germline whole exome sequencing and large-scale replication identifies FANCM as a likely high grade serous ovarian cancer susceptibility gene (2017) (16)
Transcriptome-wide association study of breast cancer risk by estrogen-receptor status (2020) (16)
Preventing Ovarian Cancer through early Excision of Tubes and late Ovarian Removal (PROTECTOR): protocol for a prospective non-randomised multi-center trial (2020) (16)
Challenges in data quality: the influence of data quality assessments on data availability and completeness in a voluntary medical male circumcision programme in Zimbabwe (2017) (16)
Complementary Longitudinal Serum Biomarkers to CA125 for Early Detection of Ovarian Cancer (2019) (16)
Global laboratory systems development: needs and approaches. (2011) (16)
LIN 28 B Polymorphisms Influence Susceptibility to Epithelial Ovarian Cancer (2011) (16)
Metabolic Profiling of Adiponectin Levels in Adults (2017) (16)
Screening for ovarian cancer (1998) (15)
Does feminism have universal relevance? The challenges posed by Oriya Hindu family practices (2000) (15)
Quality assurance and its impact on ovarian visualization rates in the multicenter United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) (2016) (15)
Novel one-stop multidisciplinary follow-up clinic significantly improves cancer risk management in BRCA1/2 carriers (2010) (15)
Novel risk models for early detection and screening of ovarian cancer (2016) (14)
The Hindu Concept of Self-refinement: Implicit yet Meaningful (2013) (14)
Comprehensive epithelial tubo-ovarian cancer risk prediction model incorporating genetic and epidemiological risk factors (2020) (14)
Serum tumour markers (2001) (14)
Ovarian cancer symptoms, routes to diagnosis and survival – Population cohort study in the ‘no screen’ arm of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) (2020) (14)
Ovarian cancer (review) (2007) (14)
Trust but verify: Is there a role for active surveillance in monitoring adverse events in Zimbabwe’s large-scale male circumcision program? (2019) (14)
Ovarian Cancer Screening and Mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): A Randomized Controlled Trial (2016) (14)
Patient-reporting improves estimates of postoperative complication rates: a prospective cohort study in gynaecological oncology (2013) (14)
Can ovarian cancer screening save lives? The question remains unanswered. (2011) (14)
Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17 q 21 . 31 (2013) (14)
Setting the Threshold for Surgical Prevention in Women at Increased Risk of Ovarian Cancer (2017) (14)
Informing Comprehensive HIV Prevention: A Situational Analysis of the HIV Prevention and Care Context, North West Province South Africa (2014) (13)
Change-point of multiple biomarkers in women with ovarian cancer (2017) (13)
Multi-Marker Longitudinal Algorithms Incorporating HE4 and CA125 in Ovarian Cancer Screening of Postmenopausal Women (2020) (13)
District Health Officer Perceptions of PEPFAR’s Influence on the Health System in Uganda, 2005-2011 (2016) (13)
Multiprobabilistic prediction in early medical diagnoses (2015) (13)
Sex hormone measurements using mass spectrometry and sensitive extraction radioimmunoassay and risk of estrogen receptor negative and positive breast cancer: Case control study in UK Collaborative Cancer Trial of Ovarian Cancer Screening (UKCTOCS) (2016) (13)
Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium (2009) (13)
Risk‐Reducing Salpingo‐Oophorectomy and the Use of Hormone Replacement Therapy Below the Age of Natural Menopause (2021) (13)
Risk reducing salpingectomy and delayed oophorectomy in high risk women: views of cancer geneticists, genetic counsellors and gynaecological oncologists in the UK (2015) (13)
Population Study of Ovarian Cancer Risk Prediction for Targeted Screening and Prevention (2020) (13)
Knowledge and Beliefs Regarding Breast and Cervical Cancer Screening Among Mexican-Heritage Latinas (2017) (13)
Postmenopausal women undergoing transvaginal ultrasound screening prefer not to have chaperones (2006) (13)
Old questions for the new anthropology of morality: A commentary (2014) (13)
Factors affecting visualization of postmenopausal ovaries: descriptive study from the multicenter United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) (2013) (13)
Refining Ovarian Cancer Test accuracy Scores (ROCkeTS): protocol for a prospective longitudinal test accuracy study to validate new risk scores in women with symptoms of suspected ovarian cancer (2016) (13)
Short-Term Effects of the COVID-19 Pandemic on HIV Care Utilization, Service Delivery, and Continuity of HIV Antiretroviral Treatment (ART) in Haiti (2021) (13)
Serum oestrogen receptor α and β bioactivity are independently associated with breast cancer: a proof of principle study (2009) (12)
Protein Phosphorylation Regulates Maize Endosperm Starch Synthase IIa Activity and Protein-Protein Interactions. (2020) (12)
Final results of 4-monthly screening in the UK Familial Ovarian Cancer Screening Study (UKFOCSS Phase 2). (2013) (12)
Ovarian cancer screening: UKCTOCS trial – Authors' reply (2016) (12)
Risk of chronic liver disease in post-menopausal women due to body mass index, alcohol and their interaction: a prospective nested cohort study within the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) (2017) (12)
Ovarian cancer screening in the general population (2000) (12)
Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study (2018) (12)
A quantitative performance study of two automatic methods for the diagnosis of ovarian cancer (2018) (12)
Opportunistic bilateral salpingectomy (OBS) for the prevention of ovarian cancer should be offered in the context of a clinical trial (2016) (12)
Menopausal hormone therapy prior to the diagnosis of ovarian cancer is associated with improved survival. (2020) (12)
Ovarian cancer screening (2002) (12)
Dietary Profiles of First-Generation South Asian Indian Adolescents in the United States (2017) (12)
Socioeconomic indicators of health inequalities and female mortality: a nested cohort study within the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) (2015) (12)
Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk. (2014) (11)
Is it all about the money? A qualitative exploration of the effects of performance-based financial incentives on Zimbabwe's voluntary male medical circumcision program (2017) (11)
PEPFAR: is 90-90-90 magical thinking? (2016) (11)
Health-related research among Amish women: a review of findings. (2002) (11)
Usability and acceptability of a two-way texting intervention for post-operative follow-up for voluntary medical male circumcision in Zimbabwe (2020) (11)
Metabolic profiles of socio-economic position: a multi-cohort analysis (2020) (11)
Screening for gynaecological cancers. (2006) (11)
Polygenic risk modeling for prediction of epithelial ovarian cancer risk (2022) (11)
Grading of serous ovarian carcinoma: further evidence of a lack of agreement between conventional grading systems (2008) (11)
DNA methylation of polycomb group target genes in cores taken from breast cancer centre and periphery (2010) (11)
PREVALENCE SCREENING FOR OVARIAN CANCER USING RISK OF OVARIAN CANCER ALGORITHM (2003) (11)
Differential diagnosis of adnexal masses: sequential use of the risk of malignancy index and HistoScanning, a novel computer‐aided diagnostic tool (2012) (11)
Application of the ConNECT Framework to Precision Health and Health Disparities (2019) (11)
Assessment of Multifactor Gene–Environment Interactions and Ovarian Cancer Risk: Candidate Genes, Obesity, and Hormone-Related Risk Factors (2016) (11)
A comprehensive gene–environment interaction analysis in Ovarian Cancer using genome‐wide significant common variants (2019) (11)
Exome genotyping arrays to identify rare and low frequency variants associated with epithelial ovarian cancer risk. (2016) (11)
Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration (2016) (10)
Multiprobabilistic Venn Predictors with Logistic Regression (2012) (10)
Early resumption of sexual activity following voluntary medical male circumcision in Botswana: A qualitative study (2017) (10)
Before and after the earthquake: a case study of attrition from the HIV antiretroviral therapy program in Haiti (2014) (10)
Modifying the health system to maximize voluntary medical male circumcision uptake: a qualitative study in Botswana (2017) (10)
Metabolic profiling of adiponectin levels in adults: Mendelian randomization analysis (2017) (10)
Behçet's disease with major vascular involvement (2013) (10)
A Longitudinal Examination of Stages of Change Model Applied to Mammography Screening (2016) (10)
Psychosocial Factors Associated With Withdrawal From the United Kingdom Collaborative Trial of Ovarian Cancer Screening After 1 Episode of Repeat Screening (2015) (10)
Reducing Provider Workload While Preserving Patient Safety: A Randomized Control Trial Using 2-Way Texting for Postoperative Follow-up in Zimbabwe's Voluntary Medical Male Circumcision Program (2019) (10)
Ovarian cancer screening has no effect on disease-specific mortality (2011) (10)
Variation in NF-κB Signaling Pathways and Survival in Invasive Epithelial Ovarian Cancer (2014) (10)
Triggering the decision to undergo medical male circumcision: a qualitative study of adult men in Botswana (2016) (10)
Cost-effectiveness analysis of two-way texting for post-operative follow-up in Zimbabwe’s voluntary medical male circumcision program (2020) (10)
Patient attrition from the HIV antiretroviral therapy program at two hospitals in Haiti. (2014) (10)
Performance of ultrasound as a second line test to serum CA125 in ovarian cancer screening (2014) (10)
Tumour markers and screening (2000) (10)
Colorectal cancer screening: an overview of current trends. (2002) (10)
Prospective Study of Bethesda Categories III and IV Thyroid Nodules: Outcomes and Predictive Value of BRAFV600E Mutation (2019) (10)
Developing hospital accreditation standards in Uganda. (2016) (9)
Similar or different? Comparing food cultures with regard to traditional and modern eating across ten countries. (2022) (9)
Metabolic profile, cardiovascular risk factors and health-related quality of life in children, adolescents and young adults with congenital adrenal hyperplasia (2019) (9)
Estimated duration of pre-clinical ovarian cancer from longitudinal CA 125 levels (1999) (9)
Polymorphisms in Stromal Genes and Susceptibility to Serous Epithelial Ovarian Cancer: A Report from the Ovarian Cancer Association Consortium (2011) (9)
Risk‐reducing early salpingectomy and delayed oophorectomy as a two‐staged alternative for primary prevention of ovarian cancer in women at increased risk: a commentary (2019) (9)
Do women participate in riots? exploring the notion of ‘militancy’ among Hindu women (2003) (9)
Association of skirt size and postmenopausal breast cancer risk in older women: a cohort study within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) (2014) (9)
Genome-Wide Association Study for Ovarian Cancer Susceptibility Using Pooled DNA (2012) (9)
Sonographers' self‐reported visualization of normal postmenopausal ovaries on transvaginal ultrasound is not reliable: results of expert review of archived images from UKCTOCS (2018) (9)
Population-based cancer screening. (2002) (9)
Hinduism, Happiness and Wellbeing: A Case Study of Adulthood in an Oriya Hindu Temple Town (2012) (9)
A prospective cohort study of safety and patient satisfaction of voluntary medical male circumcision in Botswana (2017) (9)
Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility (2018) (9)
Robust Tests for Additive Gene-Environment Interaction in Case-Control Studies Using Gene-Environment Independence (2018) (9)
Draft for public comment (2009) (9)
Breast Health Intervention Effects on Knowledge and Beliefs Over Time Among Chinese American Immigrants—a Randomized Controlled Study (2015) (9)
Need for improved detection of voluntary medical male circumcision adverse events in Mozambique: a mixed-methods assessment (2019) (8)
Assessment of clinical and nonclinical characteristics associated with health-related quality of life in patients with high-grade gliomas: a feasibility study (2014) (8)
A Systematic Review of Interventions for Sexual Well-Being in Women With Gynecologic, Anal, or Rectal Cancer. (2018) (8)
Reducing provider workload while preserving patient safety via a two-way texting intervention in Zimbabwe’s voluntary medical male circumcision program: study protocol for an un-blinded, prospective, non-inferiority, randomized controlled trial (2019) (8)
Abstract CT104: Ovarian cancer screening and mortality in the UK collaborative trial of ovarian cancer screening (UKCTOCS): A randomised controlled trial (2016) (8)
Changing trends in reproductive/lifestyle factors in UK women: descriptive study within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) (2017) (8)
Effects of a Community-to-Clinic Navigation Intervention on Colorectal Cancer Screening Among Underserved People. (2019) (8)
History of Comorbidities and Survival of Ovarian Cancer Patients, Results from the Ovarian Cancer Association Consortium (2017) (8)
Cancer Screening Barriers for Community-based Older Hispanics and Caucasians (2012) (8)
Reducing provider workload while preserving patient safety: a randomized control trial using 2-way texting for post-operative follow-up in Zimbabwe's voluntary medical male circumcision program. (2019) (8)
Setting the Threshold for Surgical Prevention in Women at Increased Risk of Ovarian Cancer. (2018) (8)
Blood levels of adiponectin and IL-1Ra distinguish type 3c from type 2 diabetes: Implications for earlier pancreatic cancer detection in new-onset diabetes (2022) (8)
Commentary on changing the risk threshold for surgical prevention of ovarian cancer (2017) (8)
Gene Set Analysis of Survival Following Ovarian Cancer Implicates Macrolide Binding and Intracellular Signaling Genes (2012) (8)
Adapting the coping in deliberation (CODE) framework: a multi-method approach in the context of familial ovarian cancer risk management. (2014) (8)
Precision health research and implementation reviewed through the conNECT framework. (2019) (7)
Attitudes towards risk‐reducing early salpingectomy with delayed oophorectomy for ovarian cancer prevention: a cohort study (2020) (7)
Balancing competing priorities: Quantity versus quality within a routine, voluntary medical male circumcision program operating at scale in Zimbabwe (2020) (7)
Delivery of health care for cardiovascular and metabolic diseases among people living with HIV/AIDS in African countries: a systematic review protocol (2016) (7)
A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancer (2016) (7)
Impact of SMS and peer navigation on retention in HIV care among adults in South Africa: results of a three‐arm cluster randomized controlled trial (2021) (7)
Recruitment to multicentre trials lessons from (2008) (7)
Self-Report Versus Medical Record for Mammography Screening Among Minority Women (2016) (7)
The Three Selves of Adulthood: Cultural Conceptions of Self Among Oriya Hindu Women (2011) (7)
Women and Household Labour (1982) (7)
Long-Term Secondary Care Costs of Endometrial Cancer: A Prospective Cohort Study Nested within the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) (2016) (7)
Agreement between questionnaires and registry data on routes to diagnosis and milestone dates of the cancer diagnostic pathway. (2020) (7)
Concordance of National Cancer Registration with self-reported breast, bowel and lung cancer in England and Wales: a prospective cohort study within the UK Collaborative Trial of Ovarian Cancer Screening (2013) (7)
The 14q32 maternally imprinted locus is a major source of longitudinally stable circulating microRNAs as measured by small RNA sequencing (2019) (7)
Familial ovarian screening – effective or ineffective? (2006) (7)
Immediate Motivators to Seeking Voluntary Medical Male Circumcision Among HIV-Negative Adult Men in an Urban Setting in Botswana. (2019) (6)
Common variants in breast cancer risk loci predispose to distinct tumor subtypes (2022) (6)
The Self-Efficacy to Communicate about Sex and Intimacy (SECSI) scale: psychometric assessment in women treated for cancer (2020) (6)
Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element (2021) (6)
Incidence of New-Onset Diabetes and PostTransplant Metabolic Syndrome after Liver Transplantation - A Prospective Study from South India (2020) (6)
Culturally Relevant Human Subjects Protection Training: A Case Study in Community-Engaged Research in the United States (2018) (6)
Diathermy-Induced Injury May Affect Detection of Occult Tubal Lesions at Risk-Reducing Salpingo-Oophorectomy (2012) (6)
The effect of ovarian cancer screening on sexual activity and functioning: results from the UK collaborative trial of ovarian cancer screening RCT (2017) (6)
Surgical decision making in premenopausal BRCA carriers considering risk-reducing early salpingectomy or salpingo-oophorectomy: a qualitative study (2020) (6)
Benchmarking of surgical complications in gynaecological oncology: prospective multicentre study (2016) (6)
Psychosocial risk profiles among black male veterans administration patients non‐adherent with colorectal cancer screening (2011) (6)
Expanding our understanding of ovarian cancer risk: the role of incomplete pregnancies. (2020) (6)
Technetium uptake predicts remission and relapse in Grave's disease patients on antithyroid drugs for at least 1 year in South Indian subjects (2016) (6)
Common breast cancer risk loci predispose to distinct tumor subtypes (2019) (6)
OSPACS: Ultrasound image management system (2008) (6)
Cancer disparities in the context of rurality: risk factors and screening across various U.S. rural classification codes (2022) (6)
A polymorphism in the GALNT2 gene and ovarian cancer risk in four population based case-control studies. (2010) (6)
Socioeconomic Status and Ovarian Cancer Stage at Diagnosis: A Study Nested Within UKCTOCS (2020) (6)
Incorporating Voluntary Medical Male Circumcision Into Traditional Circumcision Contexts: Experiences of a Local Consortium in Zimbabwe Collaborating With an Ethnic Group (2019) (6)
The role of drug resistance in poor viral suppression in rural South Africa: findings from a population-based study (2020) (6)
Sexual and Physical Violence in Childhood Is Associated With Adult Intimate Partner Violence and Nonpartner Sexual Violence in a Representative Sample of Rural South African Men and Women (2019) (6)
Design and Implementation of an External Quality Assessment Program for HIV Viral Load Measurements Using Dried Blood Spots (2014) (6)
Approach to High Volume Enrollment in Clinical Research: Experiences from an All of Us Research Program Site (2020) (5)
Women, Wellbeing, and the Ethics of Domesticity in an Odia Hindu Temple Town (2013) (5)
Mammography Screening of Chinese Immigrant Women: Ever Screened Versus Never Screened. (2015) (5)
Influences on anticipated time to ovarian cancer symptom presentation in women at increased risk compared to population risk of ovarian cancer (2017) (5)
Mathematical Models to Discriminate Between Benign and Malignant Adnexal Masses: Potential Diagnostic Improvement Using Ovarian HistoScanning (2010) (5)
Klinefelter Syndrome: Clinical Spectrum Based on 44 Consecutive Cases from a South Indian Tertiary Care Center (2019) (5)
Influences on multidisciplinary team (2008) (5)
Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8+ TIL infiltration, and provides no independent prognostic value in endometriosis‐associated ovarian carcinomas (2021) (5)
Proceedings of the 2017 Advancing the Science of Community Engaged Research (CEnR) Conference (2019) (5)
Should Opportunistic Bilateral Salpingectomy (OBS) for Prevention of Ovarian Cancer Be Incorporated Into Routine Care or Offered in the Context of a Clinical Trial? (2016) (5)
Treatment outcomes in pediatric differentiated thyroid carcinoma (2018) (5)
115 INFLUENCE OF BMI AND ALCOHOL ON LIVER-RELATED MORBIDITY AND MORTALITY IN A COHORT OF 108,000 WOMEN FROM THE GENERAL POPULATION FROM UKCTOCS (2013) (5)
Joint IARC/NCI International Cancer Seminar Series Report: Expert consensus on future directions for ovarian carcinoma research. (2021) (5)
Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American Women (2019) (5)
Epithelial ovarian cancer and induction of ovulation (2005) (5)
Health related quality of life in pediatric onset Type 1 diabetes mellitus in Kerala, India (2020) (4)
Characteristics of men responding to an invitation to undergo testing for prostate cancer as part of a randomised trial (2016) (4)
Enhanced GAB 2 Expression Is Associated with Improved Survival in High-Grade Serous Ovarian Cancer and Sensitivity to PI 3 K Inhibition (2015) (4)
Randomized controlled dissemination study of community-to-clinic navigation to promote CRC screening: Study design and implications. (2017) (4)
Role of Procalcitonin as a Predictor of Clinical Outcome in Acute Diabetic Foot Infections: A Prospective Study (2019) (4)
Development and identification of tumour markers (2005) (4)
Validation of a multi-marker panel for early detection of ovarian cancer. (2016) (4)
Histological confirmation of breast cancer registration and self-reporting in England and Wales: a cohort study within the UK Collaborative Trial of Ovarian Cancer Screening (2012) (4)
Preimplantation genetic diagnosis for hereditary cancers. (2012) (4)
Symptoms in the diagnosis of Ovarian Cancer (2007) (4)
Proteomics approaches towards early detection and diagnosis of ovarian cancer (2014) (4)
stem cells is a hallmark of cancer Age-dependent DNA methylation of genes that are suppressed in Material Supplemental (2010) (4)
Adverse event profile and associated factors following surgical voluntary medical male circumcision in two regions of Namibia, 2015–2018 (2021) (4)
Evaluating causal associations between previously reported risk factors and epithelial ovarian cancer: a Mendelian randomization analysis (2018) (4)
Need for improvements in clinical practice to retain patients in pre-antiretroviral therapy care: Data from rural clinics in North West Province, South Africa (2015) (4)
Withdrawal or Second Childhood: The Challenge of Old Age in the Temple Town of Bhubaneswar (2012) (4)
A situational analysis methodology to inform comprehensive HIV prevention and treatment programming, applied in rural South Africa (2017) (4)
rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology (2018) (4)
The Association of Disease Severity, Functional Status, and Medical Utilization with Relationship Satisfaction among Asthma Patients and Their Partners (1997) (4)
CLRC—TR—08—02 Analysis of serial UKCTOCS-OC data: discriminating abilities of proteomics peaks (2008) (4)
Screening of symptomatic women for ovarian cancer. (2012) (3)
A Pilot Study of Computerized, Tailored Intervention to Promote HPV Vaccination in Mexican-Heritage Adolescents (2017) (3)
Colorectal cancer ascertainment through cancer registries, hospital episode statistics, and self-reporting compared to confirmation by clinician: A cohort study nested within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) (2019) (3)
Conducting a Large Public Health Data Collection Project in Uganda: Methods, Tools, and Lessons Learned. (2018) (3)
No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer Survival (2016) (3)
Gynecological surveillance in high risk women. (2016) (3)
Mendelian randomisation study of smoking exposure in relation to breast cancer risk (2021) (3)
Population Testing for Inherited, Cancer Predisposing BRCA 1 and BRCA2 Founder Mutations in the Ashkenazi Jewish Community in London: The Psychological Impact on Participants of a Randomised Controlled Trial (2014) (3)
Correction: Timing of adverse events among voluntary medical male circumcision clients: Implications from routine service delivery in Zimbabwe (2018) (3)
A rare RET mutation in an Indian pedigree with familial medullary thyroid carcinoma (2020) (3)
Importance of serial CA125 measurements over an absolute cut‐off value for the detection of asymptomatic ovarian cancer in high‐risk patients (2016) (3)
Recruitment to multicentre trials—lessons from UKCTOCS: descriptive study (2008) (3)
Abstract 2838: TP53 autoantibody can detect CA125 screen negative ovarian cancer cases and can be elevated prior to CA125 in preclinical ovarian cancer (2015) (3)
Change in Airflow among Patients with Asthma Discussing Relationship Problems with Their Partners (2009) (3)
Expanded access to viral load testing and use of second line regimens in Haiti: time trends from 2010–2017 (2020) (3)
CDC Clearance Process Constitutes an Obstacle to Progress in Public Health. (2015) (3)
Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk (2020) (3)
Adapting a conceptual framework to engage diverse stakeholders in genomic/precision medicine research (2022) (3)
Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer (2016) (3)
Outcomes of Bilateral Adrenalectomy in Cushing's Syndrome (2019) (3)
Technology and Development Aid The Case of Ganga Action Plan (2016) (3)
Profiling the immune landscape in mucinous ovarian carcinoma. (2022) (3)
The value of ovarian cancer screening. (2006) (3)
Use of common analgesic medications and ovarian cancer survival: results from a pooled analysis in the Ovarian Cancer Association Consortium (2017) (3)
RESULTS OF INTENSIVE ALGORITHM-BASED SCREENING IN THE UK FAMILIAL OVARIAN CANCER SCREENING STUDY (UK FOCSS PHASE 2) (2013) (3)
Significant endometrial pathology detected during a transvaginal ultrasound screening trial for ovarian cancer (2011) (3)
Causal Associations of Adiposity and Body Fat Distribution With Coronary Heart Disease, Stroke Subtypes, and Type 2 Diabetes MellitusClinical Perspective (2017) (3)
Performance Characteristics of the Ultrasound Strategy during Incidence Screening in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) (2021) (3)
High Density Lipoprotein pathway as a therapeutic target for coronary heart disease: individual participant meta-analysis in 28,597 individuals with 4197 coronary events (2020) (3)
Modification of the Association Between Frequent Aspirin Use and Ovarian Cancer Risk: A Meta-Analysis Using Individual-Level Data From Two Ovarian Cancer Consortia (2022) (3)
Sensitivity and Specificity of Multimodal and Ultrasound Screening for Ovarian Cancer, and Stage Distribution of Detected Cancers: Results of the Prevalence Screen of the United Kingdom Collaborative Trial of Ovarian Cancer Screening (2009) (2)
Erratum to: Korean American Women and Mammogram Uptake (2015) (2)
Population based testing for high-penetrance dominant gene mutations: initial results from the pilot phase of GCaPPS (2012) (2)
Factors affecting appressoria formation by Colletotrichum corchori (1981) (2)
MALDI MS Profile Peaks for Human Blood Serum (2012) (2)
Spontaneous Bilateral Adrenal Hemorrhage of Pregnancy (2017) (2)
Ovarian cancer-tumor markers and screening (2014) (2)
Monogenic diabetes: A single center experience from South India (2020) (2)
The Need for Enemies: A Bestiary of Political Forms (2000) (2)
The current status of screening for ovarian cancer (2002) (2)
Startup and implementation costs of a colorectal cancer screening tailored navigation research study. (2021) (2)
PATENTS AND INVENTIVE ACTIVITY (1993) (2)
A Comparison of Clinicopathological Characteristics and Short-Term Outcome of Papillary Thyroid Carcinoma with Tall Cell Histology and Classic Papillary Thyroid Carcinoma: A Single-Institution Experience (2018) (2)
Insulin Autoantibody Syndrome: Varying Clinical Presentations and Response Patterns of an Underrecognized Entity (2019) (2)
Diabetic Neuropathy: Rare Presentation as a Painful Pseudoabdominal Mass (2013) (2)
Abstract 3643: Early detection of cancer in the general population - a blinded case control study of p53 auto-antibodies in colorectal cancer in UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) (2012) (2)
Two truncating variants in FANCC and breast cancer risk (2019) (2)
McGill Pain Questionnaire as a Multidimensional Measure (2009) (2)
CA125 and Other Tumor Markers in Screening and Monitoring of Ovarian Cancer (2003) (2)
Screening for gynecological cancers (2013) (2)
International Conference on Ovarian Cancer Screening: 29th–30th November 2011, Royal College of Physicians, London (2012) (2)
Did PEPFAR funding affect non-HIV health indicators? Longitudinal study of facility-based baby deliveries in Uganda, 2005–10 (2013) (2)
Receiving and giving : Distributivity as the source of women's wellbeing (1995) (2)
UK GYNAECOLOGICAL ONCOLOGY SURGICAL OUTCOMES AND COMPLICATIONS (UKGOSOC) (2013) (2)
Identifying priorities for data quality improvement within Haiti׳s iSanté EMR system: Comparing two methods (2017) (2)
Prognostic and Immunological Significance of ARID1A Status in Endometriosis-Associated Ovarian Carcinoma (2021) (2)
Mathematisation - horizontal and Vertical (2012) (2)
Erratum: Validating genetic risk associations for ovarian cancer through the International Ovarian Cancer Association Consortium (British Journal of Cancer (2009) 100 (412-420) DOI: 10.1038/sj.bjc.6604820 www.bjcancer.com) (2009) (2)
Instability adversely affects HIV care in Haiti (2016) (2)
Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study (2022) (2)
Development and identification of tumor serum markers (2013) (2)
Designing Interventions That Are Sensitive to Culture, Race/Ethnicity, and Gender (2012) (1)
Jewish cultural and religious factors and uptake of population‐based BRCA testing across denominations: a cohort study (2021) (1)
Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium (2020) (1)
Before and after the earthquake: a case study of attrition from the HIV antiretroviral therapy program in Haiti. (2014) (1)
Adaptation of colorectal cancer screening tailored navigation content for American Indian communities and early results using the intervention (2022) (1)
NICU Parent Preferences for Stakeholder Engagement in Research. (2020) (1)
Ovarian cancer (2009) (1)
Interventions to increase colorectal cancer screening (2004) (1)
Diagnostic routes and time intervals for ovarian cancer in nine international jurisdictions; findings from the International Cancer Benchmarking Partnership (ICBP) (2022) (1)
The Enhanced Liver Fibrosis test is associated with liver-related outcomes in postmenopausal women with risk factors for liver disease (2020) (1)
An assessment of data quality in Haiti's multi-site electronic medical record system (2015) (1)
Steps towards effective gynaecological cancer screening (2018) (1)
Communicating and Coaching in Spanish for Chronic Care. (2021) (1)
Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study (2018) (1)
Evidence of stage-shift in women diagnosed with ovarian cancer during Phase 2 of the UK Familial Ovarian Cancer Screening Study (UKFOCSS) (2016) (1)
Images of the Life Course (2013) (1)
0066: Sensitivity and Specificity of Transvaginal Ultrasound Screening for Endometrial Cancer in 40,000 Women From the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) (2006) (1)
Differential diagnosis of adnexal masses : A sequential use of the Risk of Malignancy Index and a novel computer aided diagnostic tool. (2012) (1)
Does data from questionnaires and cancer registries agree on routes and time intervals to diagnosis (2017) (1)
Abstract LB-176: HE4 antigen-autoantibody complexes complement CA125 for detecting early stage ovarian cancer and can be elevated with CA125 in preclinical ovarian cancer (2018) (1)
Should medical education fight international brain drain? (2009) (1)
Prostate Cancer Susceptibility Polymorphism rs2660753 Is Not Associated with Invasive Ovarian Cancer (2011) (1)
Completeness and accuracy of national cancer and death registration for outcome ascertainment in trials—an ovarian cancer exemplar (2020) (1)
Medical and psychiatric predictors of airway reactivity (1999) (1)
SYMPTOMS REPORTED BY WOMEN WITH SCREEN DETECTED INVASIVE EPITHELIAL OVARIAN CANCER IN THE UNITED KINGDOM COLLABORATIVE TRIAL OF OVARIAN CANCER SCREENING (UKCTOCS) (2015) (1)
IODINE AND THYROID STATUS IN A TRIBAL VILLAGE IN WAYANAD, KERALA IN THE POST IODIZATION ERA - OBSERVATIONS AND IMPLICATIONS (2013) (1)
Refining Ovarian Cancer Test accuracy Scores (ROCkeTS) trial update (2016) (1)
Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer. (2015) (1)
Unselected Population Genetic Testing for Personalised Ovarian Cancer Risk Prediction: A Qualitative Study Using Semi-Structured Interviews (2022) (1)
A RANDOMISED CONTROLLED TRIAL OF TARGETED SCREENING FOR OVARIAN CANCER (2004) (1)
Audit of transvaginal sonography of normal postmenopausal ovaries by sonographers from the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) (2018) (1)
Elevation of TP53 Autoantibody Prior to CA125 in Preclinical Invasive Epithelial Ovarian Cancer (2017) (1)
Association of hysterectomy and invasive epithelial ovarian and tubal cancer: a cohort study within UKCTOCS (2021) (1)
Lifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysis. (2023) (1)
Ovarian cancer screening - a case study (1999) (1)
Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study (2022) (1)
Offspring sex and risk of epithelial ovarian cancer: a multinational pooled analysis of 12 case–control studies (2020) (1)
Polygenic Risk Modelling for Prediction of Epithelial Ovarian Cancer Risk (2020) (1)
Feasibility Study: Colorectal Cancer Related Educational Program for Korean Americans (2010) (1)
Working toward sustainability: Transitioning HIV programs from a USA-based organization to a local partner in Zimbabwe (2022) (1)
There is a need for routine peritoneal cytology at RRSO. (2013) (1)
Quality improvement practices decrease adverse event rates in a surgical male circumcision program in Malawi (2015) (1)
UKCTOCS update: applying insights of delayed effects in cancer screening trials to the long-term follow-up mortality analysis (2020) (1)
Gynaecological ultrasonography: expertise counts. (2008) (1)
World Bank and transfer of technology: case of Indian fertilizer industry. (1980) (1)
Feasibility and Acceptability of a Language Concordant Health Coaching Intervention Delivered by Nurses for Latinx With Type 2 Diabetes. (2021) (1)
EXTENDING NUMBERS WITH NUMBER SENSE (2012) (1)
PTU-082 Serum CEACAM1 in the preclinical diagnosis of pancreatic adenocarcinoma (2010) (1)
Rapid adaptation of cancer screening practices during COVID-19: A multi-state qualitative study. (2022) (1)
Risk reducing salpingectomy and delayed oophorectomy in high risk women: views of cancer geneticists, genetic counsellors and gynaecological oncologists in the UK (2015) (1)
Early detection of gynaecological cancer (2013) (1)
OP0004 Testing AGR2 as an early cancer biomarker (2014) (1)
Perceptions of Cervical Cancer and Screening Behavior among Cambodian and Lao Women in the United States: An Exploratory, Mixed-Methods Study (2020) (1)
Serial endometrial thickness and risk of non‐endometrial hormone‐dependent cancers in postmenopausal women in UK Collaborative Trial of Ovarian Cancer Screening (2020) (1)
Easily missed? Ovarian cancer (2009) (1)
Mitochondrial Diabetes: More Than Just Hyperglycemia (2019) (1)
Improved early detection of ovarian cancer using longitudinal multimarker models (2020) (1)
Randomised trial of population‐based BRCA testing in Ashkenazi Jews: long‐term secondary lifestyle behavioural outcomes (2022) (1)
Women, Wellbeing, and the Ethics of Domesticity: An Introduction (2013) (1)
Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk (2022) (1)
Combination of gefitinib and methotrexate to treat tubal ectopic pregnancy (GEM3): a multicentre, randomised, double-blind, placebo-controlled trial (2023) (1)
Selected abstracts submitted to the Third International Symposium on Hereditary Breast and Ovarian Cancer (2009) (1)
Ovarian cancer prevention and screening (2018) (1)
Cognitive Interviews With Women Cancer Survivors to Assess Content Validity of the Self-Efficacy to Communicate About Sex and Intimacy (SECSI) Scale (2018) (1)
Country ownership requires public sector health system strengthening. (2014) (1)
Evaluation of an Advanced Practice Nurse–Managed Diabetes Clinic for Veterans (2010) (1)
Decreased serum thrombospondin-1 levels in pancreatic ductal adenocarcinoma patients: an early indicator of disease or diabetes mellitus development? (2015) (0)
Multiprobabilistic prediction in early medical diagnoses (2013) (0)
Tracing the Evolution of Clonal Hematopoiesis to AML Using Longitudinal Pre-Diagnosis Blood Samples (2021) (0)
Author's response to reviews Title: Impact On Mortality And Cancer Incidence Rates Of Using Random Invitation From Population Registers For Recruitment To Trials Authors: (2011) (0)
Screening of High-risk Patients for Chronic Obstructive Pulmonary Disease in Primary Care: A Narrative Review (Preprint) (2020) (0)
Lower ovarian cancer tumour volume at diagnosis on screening symptomatic women – how much of this is a ‘ healthy volunteer effect ’ ? (2012) (0)
0007: Risk of Ovarian Cancer (ROC) Algorithm Increases Specificity of Ca125 in Ovarian Cancer Screening (2006) (0)
Factors associated with colorectal cancer screening test utilization (2011) (0)
Rural–urban disparities in time to diagnosis and treatment for colorectal and breast cancer. 1,2,3 (2018) (0)
401 Population testing and personalised ovarian cancer risk prediction for risk adapted targeted prevention (2020) (0)
Full title: Self-reported transvaginal ultrasound visualization of normal ovaries in postmenopausal women is not reliable: results of expert review of archived images in UKCTOCS Short title: UKCTOCS TVS QC Authors: (2017) (0)
The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndrome (2019) (0)
Discovery and validation of serum glycoprotein biomarkers for high grade serous ovarian cancer. (2023) (0)
Registration of cancers in England and Wales (2000) (0)
Communication Among Southeast Asian Mothers and Daughters About Cervical Cancer Prevention. (2021) (0)
The double-edged sword of ovarian cancer information for women at increased risk who have previously taken part in screening (2016) (0)
Decreased Serum Thrombospondin-1 Levels in Pancreatic Ductal Adenocarcinoma Patients: An Early Indicator of Cancer or Diabetes Development? (2015) (0)
Enhanced liver fibrosis test predicts liver-related outcomes in postmenopausal women with risk factors in the community (2018) (0)
Sexual health and intimacy after cancer treatment in women of color: A systematic review (2022) (0)
Recruitment Challenges of a Colorectal Cancer Screening Dissemination Study (2022) (0)
Care after premenopausal risk-reducing salpingo-oophorectomy in high-risk women: Scoping review and international consensus recommendations. (2023) (0)
Tumor markers (2018) (0)
0733: Cancer and Social Deprivation in the United Kingdom Collaborative Trial of Ovarian Cancer Screening (Ukctocs) (2006) (0)
1 LIN 28 B polymorphisms influence susceptibility to epithelial ovarian cancer (2011) (0)
NICU Parent Preferences for Stakeholder Engagement in Research. (2020) (0)
UK–EDI: Detecting Pancreatic Cancer with DM (2020) (0)
Influences on anticipated time to ovarian cancer symptom presentation in women at increased risk compared to population risk of ovarian cancer (2017) (0)
randomization Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study (2016) (0)
UKCTOCS: descriptive study Recruitment to multicentre trialslessons from (2008) (0)
Perceived Discrimination and Mental Health in Asian-American and Pacific Islander College and Graduate Students (2012) (0)
Abstract 2927: MicroRNA binding site polymorphisms influence ovarian cancer risk in the collaborative oncological gene-environment study (2012) (0)
Translational Research: Dissemination and Implementation of Interventions From Research to Practice (2017) (0)
Determinants of Quality of Life in Brain Cancer Patients: Preliminary Results (2010) (0)
Challenges of Cognitive Interviewing in Sensitive Health Topic Research (2021) (0)
00059 THE NEED TO CONTINUE SCREENING STUDIES IN HIGH RISK POPULATION (2005) (0)
FEASIBILITY OF A TARGETED BREAST HEALTH INTERVENTION FOR CHINESES IMMIGRANT WOMEN (2012) (0)
ESICON 2017 Abstracts (2017) (0)
iTRAQ Reveals a Serum Marker Significantly Altered in Patients up to 24 Months Prior to Diagnosis With Pancreatic Cancer (2013) (0)
ESICON 2017 Abstracts (2017) (0)
PROTEOMIC DISCOVERY OF CANDIDATE SERUM BIOMARKERS FOR EARLY DETECTION OF OVARIAN CANCER (2014) (0)
OC-006 Influence of BMI and Alcohol on Liver-Related Morbidity and Mortality in a Cohort of 108,000 Women from the General Population from Ukctocs (2013) (0)
Polygenic risk modeling for prediction of epithelial ovarian cancer risk (2022) (0)
Conformal Predictors in Risk Assessment of Ovarian and Breast Cancers (2012) (0)
Mammography Promotion Intervention for Korean American Immigrant Women (2007) (0)
Performance characteristics and stage distribution of invasive epithelial ovarian/tubal/peritoneal cancers in UKCTOCS. (2016) (0)
Computational learning methods for early detection of ovarian cancer (2021) (0)
2022-RA-1490-ESGO The quality of life of female refuges patients from Ukraine with malignant gynaecological tumors before and after treatment in Germany (2022) (0)
Association of adult attachment with delays in accessing specialist care in women with ovarian cancer (2022) (0)
Abstract IA03: Digital health and health equity (2020) (0)
Development of Multiple Reaction Monitoring techniques for the quantification of biomarkers of pancreatic cancer (2011) (0)
Socioeconomic inequalities in mortality in national sample of English women: the UKCTOCS Study (2014) (0)
Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk (2022) (0)
and Mammogram Uptake. (2015) (0)
MUC16, alias CA125 and ovarian cancer (2013) (0)
The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndrome (2019) (0)
000102 PROGRESS IN THE UK FAMILIAL OVARIAN CANCER SCREENING STUDY (UKFOCSS) (2005) (0)
Cushings syndrome due to carneys complex - case series and a report of a new mutation from South Indian Tertiary care centre (2016) (0)
Prevalence of thyroid disorders is not different in type 2 diabetes mellitus compared to nondiabetics in South India (2018) (0)
Health Belief Model Scale for Cervical Cancer Screening--Korean Version (2016) (0)
A robust and sensitive automated method for MS-based serum pattern diagnostics using well-established ZipTip technology and ultrafiltration (2008) (0)
An Alternate Moral Order (2013) (0)
Breast Health Intervention Effects on Knowledge and Beliefs Over Time Among Chinese American Immigrants—a Randomized Controlled Study (2014) (0)
An extensive peptide identification list of MALDI MS profile peaks from the analysis of human blood serum (2009) (0)
In another vein: The potential of 'object handling' for women facing a gynaecological cancer diagnosis (2007) (0)
Cigarette smoking and risk of ovarian cancer: a pooled analysis of 21 case–control studies (2013) (0)
The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer (2019) (0)
High Prediagnosis Inflammation-Related Risk Score Associated with Decreased Ovarian Cancer Survival (2021) (0)
Introduction. Universalism without Uniformity (2019) (0)
Indian Thought and Modern Psychology in the West: Kipling had it Wrong—the Twain do Meet after all! (2001) (0)
Colon Cancer beliefs among Hispanics and Caucasians (2011) (0)
Common variants in breast cancer risk loci predispose to distinct tumor subtypes (2022) (0)
SPECIAL SESSION: A Research Journey: To Boldly Go Forward (2014) (0)
TESTING AGR2 AS AN EARLY CANCER BIOMARKER (2014) (0)
BRCA-carrier identification offers opportunities for early-diagnoses, targeted treatment and cancer prevention. We evaluate BRCA-carrier detection rates in General and Ashkenazi-Jewish(AJ) populations across Greater-London and estimate time-to-detection of all identifiable BRCA-carriers. Methods BRC (2018) (0)
A psychosocial study on forms of discrimination against the girl child a life cycle approach (2014) (0)
Agreement between questionnaires and registry data on routes and time intervals to cancer diagnos (2016) (0)
Cancer Screening Among Rural and Urban Clinics During COVID-19: A Multistate Qualitative Study (2022) (0)
Gynaecological surveillance in high risk women (2016) (0)
Abstract PL02-04: Considerations of culture in behavior change interventions (2009) (0)
ESICON 2018 Abstracts (2018) (0)
QUALITY OF LIFE IN ENDOMETRIAL CANCER SURVIVORS - A COHORT STUDY NESTED WITHIN THE UNITED KINGDOM COLLABORATIVE TRIAL OF OVARIAN CANCER SCREENING (UKCTOCS) (2015) (0)
423 Results of the avoiding late diagnosis of ovarian cancer (ALDO) project; a pilot national surveillance program for BRCA mutation-carriers (2021) (0)
Title Use of common analgesic medications and ovarian cancer survival : results from a pooled analysis in the Ovarian Cancer Association Consortium Permalink (2017) (0)
Reply to P.F. Pinsky, C.P. Crum, and M.W. McIntosh et al. (2016) (0)
Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry (2023) (0)
Odia Hindu Ways of Thinking (2013) (0)
Book Reviews (2011) (0)
Department of Error (2016) (0)
Early detection of pancreatic ductal adenocarcinomas with an ensemble learning model based on a panel of protein serum biomarkers (2021) (0)
Impact of SMS and Peer Navigation on linkage to care and ART initiation in South Africa: secondary results from a three-arm cluster randomized controlled trial. (2022) (0)
CLINICAL CASE Should Medical Education Fight International Brain Drain (2009) (0)
POPULATION-BASED TESTING FOR BRCA MUTATIONS (COMPARED TO FAMILY-HISTORY BASED TESTING) MAY BE COST SAVING IN ASHKENAZI-JEWS: A HEALTH-ECONOMICS DECISION ANALYTICAL MODEL (2014) (0)
Cost-Effectiveness of Community-to-Clinic Tailored Navigation for Colorectal Cancer Screening in an Underserved Population: Economic Evaluation Alongside a Group-Randomized Trial (2022) (0)
Early detection of hereditary gynaecological cancers (2014) (0)
Abstract PO-258: Cancer risk factors and screening across various U.S. rural classification codes: Cancer disparities in the context of rurality (2020) (0)
Familial ovarian screening - : effective or ineffective? Authors' reply (2006) (0)
A sequential use of the Risk of Malignancy Index and Ovarian HistoScanning for the differential diagnosis of adnexal masses (2009) (0)
REDCap mobile data collection: Using implementation science to explore the potential and pitfalls of a digital health tool in routine voluntary medical male circumcision outreach settings in Zimbabwe (2022) (0)
Assessing the genetic architecture of epithelial ovarian cancer histological subtypes (2016) (0)
How detecting change-points in biomarkers time series can support the diagnostic approaches of ovarian cancer (2018) (0)
BIOMARKERS FOR SCREENING AND EARLY DETECTION OF OVARIAN CANCER (2010) (0)
A TIME SERIES ALGORITHM DOUBLES SENSITIVITY OF POPULATION SCREENING FOR OVARIAN CANCER IN THE UNITED KINGDOM COLLABORATIVE TRIAL OF OVARIAN CANCER SCREENING (UKCTOCS) (2014) (0)
Department of Error (2016) (0)
EP1231 Impact of population genetic testing and ovarian cancer risk stratification on the emotional well-being and health of unselected women in a general population (2019) (0)
00063 THE FEASIBILITY OF SCREENING WOMEN WITH NONSPECIFIC SYMPTOMS FOR OVARIAN CANCER (2005) (0)
Randomised trial of unselected BRCA testing in ashkenazi jews: long term outcomes and factors affecting uptake of testing (2019) (0)
ESICON 2019 Abstracts (2019) (0)
Reproductive factors do not influence survival with ovarian cancer. (2022) (0)
PDAC-associated fibroblasts are less responsive to an anti-fibrotic stimulus and more responsive to a positive regulator of fibroblast activation than normal activated fibroblasts (2019) (0)
Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer (2019) (0)
MICROPAPILLARY ARCHITECTURE AND MORPHOLOGICAL ‘TRANSITION’ IN INVASIVE SEROUS OVARIAN CARCINOMA: CLINICOPATHOLOGIC AND PROGNOSTIC IMPLICATIONS (2004) (0)
CA19.9 profile in samples pre-dating pancreatic cancer diagnosis - nested case control study in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) (2013) (0)
Medical Monitoring at a Large Former Nuclear Weapons Production Facility: Use of a Computer-based Hazard Assessment Tool and Application of Lymphocyte Proliferation Test for Beryllium (1999) (0)
Managing the Household: Achieving Control, Being Productive, Distributing Resources (2013) (0)
A Brief Telephone Intervention Fails to Improve Follow-up after Emergency Department Discharge (2002) (0)
Electronic Poster Presentations, Gynae‐Oncology (2015) (0)
A Cultural-Based approach to address substance use among urban Native American young adults. (2023) (0)
Reply (2014) (0)
Abstract IA23: Ovarian cancer screening. (2016) (0)
The Social Mission of Medical Education. Authors' reply (2010) (0)
A BRCA1-mutation associated DNA methylation signature in blood cells predicts sporadic breast cancer incidence and survival (2014) (0)
Current developments in ovarian cancer screening (2012) (0)
The social mission of medical education. (2010) (0)
Impact of short message service and peer navigation on linkage to care and antiretroviral therapy initiation in South Africa (2022) (0)
81 Attitude towards and factors affecting uptake of population based BRCA testing in ashkenazi jews: a cohort study (2019) (0)
Urethrocutaneous fistula following VMMC: a case series from March 2013 to October 2019 in ZAZIC’s voluntary medical male circumcision program in Zimbabwe (2021) (0)
9th Joint Meeting of the British Division of the International Academy of Pathology and the Pathological Society of Great Britain & Ireland 28 June-1 July 2016 Abstract (2016) (0)
Social 'Service-Innovation' (2008) (0)
Efficacy of a language-concordant health coaching intervention for latinx with diabetes. (2021) (0)
Methylation patterns in serum DNA for early identification of disseminated breast cancer (2017) (0)
TRIPS NEGOTIATIONS AND INDIAN AGRICULTURE (1993) (0)
Evaluation of a comprehensive HIV prevention program in North West Province, South Africa: Results from the pilot (2014) (0)
Managing Life and Its Processes (2013) (0)
Champion Breast Cancer Fear Scale (2012) (0)
ESICON 2019 Abstracts (2019) (0)
Prevalence, motivation, and outcomes of clinic transfer in a clinical cohort of people living with HIV in North West Province, South Africa (2022) (0)
Abstract 797: A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancer (2016) (0)
SERIAL CA125 CAN DETECT OVARIAN CANCER IN THE ABSENCE OF ULTRASOUND ABNORMALITIES (2014) (0)
FIELD MANUAL For Data Collectors at the facility level (2012) (0)
Corrigendum to “Sex hormone measurements using mass spectrometry and sensitive extraction radioimmunoassay and risk of estrogen receptor negative and positive breast cancer: Case control study in UK Collaborative Cancer Trial of Ovarian Cancer Screening (UKCTOCS)” [Steroids 110 (2016) 62–69] (2016) (0)
From RCT to Scale: Can a Digital Health Innovation Make the Leap? (2022) (0)
Investigation of Exomic Variants Associated with Overall Survival in Ovarian Cancer (2016) (0)
Safety and efficacy of the PrePex device in HIV-positive men: A single-arm study in Zimbabwe (2017) (0)
Adapting Interventions to Diverse Populations (2013) (0)
Using an electronic medical record system to identify factors associated with attrition from the HIV antiretroviral therapy program at two hospitals in Haiti (2014) (0)
P2.105 The development of positive allosteric modulators of mGluR4 for the treatment of Parkinson's disease (2009) (0)
ASelectiveAllostericPotentiatoroftheM 1 Muscarinic AcetylcholineReceptorIncreasesActivityofMedial PrefrontalCorticalNeuronsandRestoresImpairments inReversalLearning (2009) (0)
Dissemination and Implementation of a Cervical Cancer Screen and Treatment Program in Ethiopia (2017) (0)
Cost-effectiveness of systematic population based screening for BRCA1, BRCA2, RAD51C, RAD51D and BRIP1 gene mutations in unselected general population women (2016) (0)
Universalism without uniformity (2017) (0)
Variation in NFk B Signaling Pathways and Survival in Invasive Epithelial Ovarian Cancer (2014) (0)
Ovarian Cancer Histotype Diagnosis in the UK: A Review of Cases From 5 Hospitals From 2002-2008 (2015) (0)
Establishment of a biorepository of paediatric cancers: The Tata Medical Center experience (2017) (0)
Old Age and Hinduism (2018) (0)
CCNE1 and survival of patients with tubo‐ovarian high‐grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study (2022) (0)
Abstract KP01: UNITED KINGDOM COLLABORATIVE TRIAL OF OVARIAN CANCER SCREENING – (UKCTOCS) – EXPLORING THE RESULTS (2017) (0)
Abstract B004: Capacity development among patient navigators to enhance colorectal cancer control in American Indian-serving healthcare facilities in the U.S. Southwest and Southern Plains (2020) (0)
Making the Case: The Impetus for Federally Mandating Insurance Companies to Cover Colorectal Cancer Screening (2010) (0)
The Prevalence And Clinical Significance Of Mutations BRIP 1 , BARD 1 , PALB 2 And NBN Genes In Women With Ovarian Cancer (2017) (0)
PopulationDistributionofLifetimeRiskofOvarian Cancer in the United States (2015) (0)
Diagnosis of Ovarian Cancer Based on Longitudinal Measurements of Multiple Biomarkers (2018) (0)
Cancer of the Ovary: Ovarian Cancer Screening (2006) (0)
Registration of ovarian cancer in England and Wales (2000) (0)
0193: Symptoms in Women with Ovarian Cancer Compared to Those Referred for Targeted Ovarian Screening (2006) (0)
OVERDIAGNOSIS OF BORDERLINE OVARIAN CANCER IN OVARIAN CANCER SCREENING: THE UK COLLABORATIVE TRIAL OF OVARIAN CANCER SCREENING (UKCTOCS) EXPERIENCE (2015) (0)
Exploring Patients’ Needs and Desires for Quality Prenatal Care in Florida, United States (2023) (0)
Among Chinese American Immigrants Measuring Breast Cancer and Mammography Screening Beliefs (2014) (0)
0191: Evaluation of Pre-Analytic Influence of Sample Collection/Handling Methodologies On Serum Proteome is Key in Biomarker Discovery and Assay Development (2006) (0)
Reply: To PMID 23456790. (2014) (0)
Colon Cancer Screening Beliefs by Stage of Behavior Adoption (2011) (0)
Prevention and Epidemiology LIN 28 B Polymorphisms Influence Susceptibility to Epithelial Ovarian Cancer (2011) (0)
Diagnostic pathways for breast cancer in 10 International Cancer Benchmarking Partnership (ICBP) jurisdictions: an international comparative cohort study based on questionnaire and registry data (2022) (0)
A well‐characterised peak identification list of MALDI MS profile peaks for human blood serum (2010) (0)
LET'S TALK ABOUT CERVICAL CANCER: A QUALITATIVE STUDY WITH SE ASIAN WOMEN (2015) (0)
Serum biomarker-based early detection of pancreatic ductal adenocarcinomas with ensemble learning (2023) (0)
A polymorphism in the GALNT 2 gene and ovarian cancer risk in four population based case-control studies (2011) (0)
Pilot Test of a Language-Concordant Health Coaching Intervention for Limited English Proficiency Latinx (2019) (0)
Language Concordant Health Coaching on Diabetes Self-Management for Limited English Proficiency Latinx (2019) (0)
Announcement of the Best Paper Awards 2011 (2012) (0)
The Auspicious Heart: Influence, Productivity, and Coherence (2013) (0)
Conformal predictors in early diagnostics of ovarian and breast cancers (2012) (0)
Cancer and Reproductive Health: Serum markers for gynaecological cancer in the reproductive years (2008) (0)
Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses (2020) (0)
Midlife Narratives Across Cultures (2015) (0)
0256: Morphological Transition in Serous and Muci- Nous Ovarian Neoplasia (2006) (0)
Research Designs for Dissemination and Implementation (2014) (0)
If you build it, will they come? Describing the process of building community capacity for intervention research with underserved minority populations (2013) (0)
ROLE OF RELATIONSHIP STYLE IN DELAYING HELP SEEKING FROM AN ONCOLOGIST IN WOMEN WITH OVARIAN CANCER (2019) (0)
Refining Ovarian Cancer Test accuracy Scores ( ROCkeTS ) (2016) (0)
Association of Frequent Aspirin Use With Ovarian Cancer Risk According to Genetic Susceptibility (2023) (0)
ANTICIPATED PRESENTATION TO HEALTH PROFESSIONALS WITH OVARIAN CANCER SYMPTOMS IN GENETIC RISK VERSUS POPULATION SAMPLES (2014) (0)
Association between skirt size and chronic liver disease in post-menopausal women: a prospective cohort study within the United Kingdom Trial of Ovarian Cancer Screening (UKCTOCS) (2018) (0)
A new blood test uses DNA methylation to detect and predict the spread of breast cancer (2020) (0)
Mendelian randomization Association of vitamin D levels and risk of ovarian cancer : a Mendelian randomization study (2016) (0)
Abstract POSTER-CTRL-1213: Whole exome and targeted resequencing, of population based ovarian cancer cases and controls, identifies susceptibility genes for ovarian cancer (2015) (0)
0243: Preimplantation Genetic Diagnosis - What Brca1 and 2 Gene Carriers Think (2006) (0)
SEXUAL BEHAVIORS IN ASIAN AMERICAN AND PACIFIC ISLANDER YOUNG ADULTS (2012) (0)
Breast Cancer Risk and Mammograms: Korean-American Spousal Interactions (2012) (0)
The potential of circulating tumor DNA methylation analysis for the early detection and management of ovarian cancer (2017) (0)
p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study (2023) (0)
Circulating tenascin C levels distinguish pancreatic cancer from chronic pancreatitis and correlate with pancreatic stromal expression (2016) (0)
POPULATION PREVALENCE OF UK ASHKENAZI BRCA-MUTATIONS, PERFORMANCE OF AND ESTIMATED TIME-TO, FAMILY-HISTORY BASED IDENTIFICATION OF ALL BRCA CARRIERS. (2014) (0)
Withdrawal or Second Childhood: The Challenge of Old Age in the Temple Town of Bhubaneswar (2012) (0)
Predictors of Achieving Glycemic Targets among People with Type 2 Diabetes—The CARRS Trial (2018) (0)
Diagnosis of breast cancer (2011) (0)
International Nurse Researcher Hall of Fame and Conversation with the Honorees (2014) (0)
Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci (2022) (0)
T1394 Serum CEACAM1 in the Preclinical Diagnosis of Pancreatic Adenocarcinoma (2010) (0)
From First Symptom To Treatment For Breast Cancer - An International Comparative Study (ICBPM4) (2016) (0)
A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer (2018) (0)
The Need for Enemies (Book Review). (2000) (0)
Specifying the threshold of 'ovarian cancer risk' for undertaking risk reducing surgery for ovarian cancer prevention in premenopausal women (2016) (0)
Entering the Temple Town of Bhubaneswar (2013) (0)
Rural-Urban Variation in Time to Diagnosis and Treatment of Colorectal or Breast Cancer in Victoria, Australia (2018) (0)
DETECTION OF NON-OVARIAN CANCERS ON PHASE 2 OF THE UK FAMILIAL OVARIAN CANCER SCREENING STUDY (UKFOCSS) (2013) (0)
Translating Interventions to Practice: Dissemination and Implementation Research Methods (2014) (0)
A NON-INFERIORITY CLUSTER RANDOMISED TRIAL COMPARING TRADITIONAL FACE-TO-FACE AND DVD-BASED GENETIC COUNSELLING IN SYSTEMATIC POPULATION BASED BRCA1/2 TESTING (2015) (0)
Self-Efficacy Scale for Mammography (2016) (0)
THE INCIDENCE OF MORPHOLOGICAL ‘TRANSITION’ IN SEROUS AND MUCINOUS OVARIAN NEOPLASIA (2004) (0)
Profiles of women’s adjustment after cancer based on sexual and psychosocial wellbeing: results of a cluster analysis (2022) (0)
Perceptions of Femaleness (2013) (0)
Hindu Views of Childhood and Child Rearing (2017) (0)
Access to and transfer of genetic resources (2014) (0)
Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA (2013) (0)
POPULATION BASED TESTING FOR BRCA MUTATIONS IS HIGHLY COST-EFFECTIVE COMPARED TO FAMILY HISTORY BASED APPROACH: A HEALTH-ECONOMIC DECISION ANALYTICAL MODEL FROM THE GCAPPS TRIAL (2013) (0)
Is the Qobeess a feminist ? the politics of south Asian qoà (2008) (0)
Cultural Patterns of Decision-Making Related to Condom Use Among Men Who Have Sex with Men in Mumbai, India (2012) (0)
EP1229 Preventing ovarian cancer through early excision of tubes and late ovarian removal (PROTECTOR) study (2019) (0)
The cost-effectiveness of screening for ovarian cancer : results from the UK Collaborative Trial of Ovarian Cancer Screening (2017) (0)
Implementation of a Continuing Education Program for Frontline Nurses During the COVID-19 Pandemic. (2022) (0)
Original Article A polymorphism in the GALNT2 gene and ovarian cancer risk in four population based case-control studies (2010) (0)
Early Detection Biomarkers and Risk Estimation Models for Ovarian Cancer (2016) (0)
Spousal Interaction and Breast Cancer Screening Among Korean Americans (2018) (0)
THE PRECLINICAL DETECTION OF NON-HODGKIN'S LYMPHOMA THROUGH SERIAL MEASUREMENTS OF SERUM CA 125 AMONG POSTMENOPAUSAL WOMEN PARTICIPATING IN THE UNITED KINGDOM COLLABORATIVE TRIAL OF OVARIAN CANCER SCREENING (2016) (0)

This paper list is powered by the following services:

Other Resources About Usha Menon

en.wikipedia.org

What Schools Are Affiliated With Usha Menon?

Usha Menon is affiliated with the following schools: